このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
Tasly Pharmaceutical Group 配当金
配当金 基準チェック /56
Tasly Pharmaceutical Group is a dividend paying company with a current yield of 2.44% that is well covered by earnings.
主要情報
2.4%
配当利回り
45%
配当性向
業界平均利回り | 1.8% |
次回配当支払日 | n/a |
配当落ち日 | n/a |
一株当たり配当金 | n/a |
一株当たり利益 | CN¥0.74 |
3年後の配当利回り予想 | 3.1% |
最近の配当金アップデート
更新なし
Recent updates
Estimating The Intrinsic Value Of Tasly Pharmaceutical Group Co., Ltd (SHSE:600535)
Jun 13The Market Doesn't Like What It Sees From Tasly Pharmaceutical Group Co., Ltd's (SHSE:600535) Earnings Yet
May 13Tasly Pharmaceutical Group's (SHSE:600535) Solid Earnings Have Been Accounted For Conservatively
Apr 26Does Tasly Pharmaceutical Group (SHSE:600535) Have A Healthy Balance Sheet?
Mar 15決済の安定と成長
配当データの取得
安定した配当: 600535's dividend payments have been volatile in the past 10 years.
増加する配当: 600535's dividend payments have increased over the past 10 years.
配当利回り対市場
Tasly Pharmaceutical Group 配当利回り対市場 |
---|
セグメント | 配当利回り |
---|---|
会社 (600535) | 2.4% |
市場下位25% (CN) | 0.7% |
市場トップ25% (CN) | 2.4% |
業界平均 (Pharmaceuticals) | 1.8% |
3年後のアナリスト予想 (600535) | 3.1% |
注目すべき配当: 600535's dividend (2.44%) is higher than the bottom 25% of dividend payers in the CN market (0.67%).
高配当: 600535's dividend (2.44%) is in the top 25% of dividend payers in the CN market (2.43%)
株主への利益配当
収益カバレッジ: With its reasonably low payout ratio (44.8%), 600535's dividend payments are well covered by earnings.
株主配当金
キャッシュフローカバレッジ: With its reasonably low cash payout ratio (31.8%), 600535's dividend payments are well covered by cash flows.